Cargando…

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A

INTRODUCTION: Treatment of breast cancer is becoming more individualized with the recognition of tumor subgroups that respond differently to available therapies. Breast cancer 1 gene (BRCA1)-deficient tumors are usually of the basal subtype and associated with poor survival rates, highlighting the n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puppe, Julian, Drost, Rinske, Liu, Xiaoling, Joosse, Simon A, Evers, Bastiaan, Cornelissen-Steijger, Paulien, Nederlof, Petra, Yu, Qiang, Jonkers, Jos, van Lohuizen, Maarten, Pietersen, Alexandra M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750125/ https://www.ncbi.nlm.nih.gov/pubmed/19709408 http://dx.doi.org/10.1186/bcr2354

Ejemplares similares

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
por: Pietersen, Alexandra M, et al.
Publicado: (2008)

Large variety in a panel of human colon cancer organoids in response to EZH2 inhibition
por: Koppens, Martijn AJ, et al.
Publicado: (2016)

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
por: Ratz, Leonie, et al.
Publicado: (2022)

Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
por: Holstege, Henne, et al.
Publicado: (2010)

The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
por: Steele, J C, et al.
Publicado: (2006)

3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
por: Girard, Nicolas, et al.
Publicado: (2014)

Preclinical mouse models for BRCA1-associated breast cancer
por: Drost, R M, et al.
Publicado: (2009)

Going beyond Polycomb: EZH2 Functions in Prostate Cancer
por: Park, Su H., et al.
Publicado: (2021)

Polycomb-independent activity of EZH2 in castration resistant prostate cancer
por: Xu, Kexin, et al.
Publicado: (2013)

Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
por: Kim, Jung, et al.
Publicado: (2018)

Deazaneplanocin A Is a Promising Drug to Kill Multiple Myeloma Cells in Their Niche
por: Gaudichon, Jérémie, et al.
Publicado: (2014)

TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development
por: Cornelissen, Lisette M., et al.
Publicado: (2020)

The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
por: Li, Zhongwu, et al.
Publicado: (2013)

Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31
por: Zhang, Q, et al.
Publicado: (2014)

Epigenetically Reprogramming of Human Embryonic Stem Cells by 3-Deazaneplanocin A and Sodium Butyrate
por: Azghadi, Soheila, et al.
Publicado: (2011)

3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation
por: Fujiwara, Tohru, et al.
Publicado: (2014)

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
por: Vollebergh, Marieke A, et al.
Publicado: (2014)

Functional Anatomy of Polycomb and Trithorax Chromatin Landscapes in Drosophila Embryos
por: Schuettengruber, Bernd, et al.
Publicado: (2009)

The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets
por: Van Dessel, Nele, et al.
Publicado: (2010)

Polycomb repressive complex’s evolutionary conserved function: the role of EZH2 status and cellular background
por: Gall Trošelj, Koraljka, et al.
Publicado: (2016)

EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors
por: Zander, Serge A. L., et al.
Publicado: (2012)

The Polycomb Protein and E3 Ubiquitin Ligase Ring1B Harbors an IRES in its Highly Conserved 5′ UTR
por: Boutsma, Erwin, et al.
Publicado: (2008)

Interactions among Polycomb Domains Are Guided by Chromosome Architecture
por: Tolhuis, Bas, et al.
Publicado: (2011)

Significance of EZH2 expression in canine mammary tumors
por: Choi, Hyun-Ji, et al.
Publicado: (2016)

EZH2 takes the stage when BRCA1 loses
por: Wang, Lan, et al.
Publicado: (2013)

HTLV-1 Tax disrupts the host epigenome by interacting with a Polycomb group protein EZH2
por: Fujikawa, Dai, et al.
Publicado: (2014)

EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation
por: Mu, Weipeng, et al.
Publicado: (2018)

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022)

Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin
por: Schipper, Koen, et al.
Publicado: (2019)

Anti-inflammatory and chondroprotective effects of the S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin A, in human articular chondrocytes
por: Aury-Landas, Juliette, et al.
Publicado: (2017)

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
por: Holstege, Henne, et al.
Publicado: (2010)

Polycomb Group Protein Ezh2 Regulates Hepatic Progenitor Cell Proliferation and Differentiation in Murine Embryonic Liver
por: Koike, Hiroyuki, et al.
Publicado: (2014)

The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids
por: Yang, Qiwei, et al.
Publicado: (2016)

Polycomb Repressive Complex 2 Modulation through the Development of EZH2–EED Interaction Inhibitors and EED Binders
por: Tomassi, Stefano, et al.
Publicado: (2021)

Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors
por: Bhin, Jinhyuk, et al.
Publicado: (2023)

Tumor Necrosis Factor-Alpha and Apoptosis Induction in Melanoma Cells through Histone Modification by 3-Deazaneplanocin A
por: Tanaka, Ryo, et al.
Publicado: (2013)

Evaluation of the impact of S-adenosylmethionine-dependent methyltransferase inhibitor, 3-deazaneplanocin A, on tissue injury and cognitive function in mice
por: Lhuissier, Eva, et al.
Publicado: (2018)

A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A
por: Zeybel, Müjdat, et al.
Publicado: (2017)

GFAP-Cre-Mediated Transgenic Activation of Bmi1 Results in Pituitary Tumors
por: Westerman, Bart A., et al.
Publicado: (2012)

The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart
por: Mathiyalagan, Prabhu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9kmpr48q1h678av4rboif9vmac